This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bozikas, V. Articles by Karavatos, A. Search for Related Content PubMed PubMed Citation Articles by Bozikas, V. Articles by Karavatos, A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB FLUOXETINE Social Bookmarking                         What's this?

Urinary retention caused after fluoxetine–risperidone combination

P. Petrikis

A. Karavatos

A' Psychiatric Clinic, Aristotle University of Thessaloniki, Thessaloniki, Greece

A case of urinary retention emerging after fluoxetine (20 mg/day) addition to low risperidone doses (2 mg/day) is presented. Severe extrapyramidal side-effects (EPS) also occurred after fluoxetine–risperidone combination. Several possibilities, based on the pharmacodynamic and pharmacokinetic properties of risperidone and fluoxetine, which merit consideration in an attempt to explain our patient's side-effects, are discussed. Extrapyramidal side-effects can be due to an increase of the plasma concentration of risperidone and/or the intrinsic propensity of fluoxetine to produce EPS. Urinary retention may be the consequence of a central serotoninergic mechanism in, or without, combination central D2 blockade.

Key Words: extrapyramidalside-effects • fluoxetine • risperidone • urinaryretention

Journal of Psychopharmacology, Vol. 15, No. 2, 142-143 (2001)
DOI: 10.1177/026988110101500201


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?